15993011000001101: Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Saxagliptin 5mg tablets\Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Saxagliptin\Saxagliptin 5mg tablets\Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
\UK product\Trade family\Onglyza\Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing peptide hydrolase inhibitor\Product containing dipeptidyl peptidase IV inhibitor\Product containing saxagliptin\Saxagliptin\Saxagliptin 5mg tablets\Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing saxagliptin\Saxagliptin\Saxagliptin 5mg tablets\Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing saxagliptin\Saxagliptin\Saxagliptin 5mg tablets\Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

56862601000001119 Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

80002701000001115 Onglyza 5mg tablets (AstraZeneca UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Is a	Saxagliptin 5mg tablets	false	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Is a	Saxagliptin 5mg tablets	true	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Is a	Saxagliptin 5mg tablets	false	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has specific active ingredient	Saxagliptin hydrochloride	false	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Saxagliptin	false	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Is a	Onglyza	true	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Saxagliptin	true	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has active ingredient	Saxagliptin	false	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Is a	Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has basis of strength substance	Saxagliptin	true	Inferred relationship	Existential restriction modifier
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has specific active ingredient	Saxagliptin hydrochloride	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets	Has AMP	True	Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
56862601000001119	Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
80002701000001115	Onglyza 5mg tablets (AstraZeneca UK Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module